Hannah Mamuszka insider trades
Open-market stock purchases and sales by Hannah Mamuszka, Director at Bionano Genomics, Inc, from SEC Form 4 filings since May 4, 2020.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +61%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BNGO Bionano Genomics, Inc: 1 buy, last Jun 11, 2025